The Safecare Group Introduces AI Software Suite To Reduce Avoidable Hospital Readmissions

The SafeCare Group® has launched the SafeCare AI Suite, a comprehensive Artificial Intelligence (AI) software suite to aid proactive real-time decision support and target opportunities of care to cut avoidable hospital readmissions.

"Hospital readmissions are frequent, harmful and costly affecting 18 percent of Medicare patients," stated Yisrael Safeek, MD, MBA, CEO and Chairman, The SafeCare Group. "Over 2.3 million patients are readmitted within 30 days after discharge annually, incurring an annual extra cost of 17 billion dollars."

SafeCare AI software is able to extract and process valuable insight from EMR data in real-time, close to the data source, to transform it into knowledge to support instantaneous decision-making while cutting avoidable hospital readmissions.

Dr. Safeek stated:

The SafeCare Group invested heavily into AI to realize game-changing clinical, operational, and financial opportunities for hospitals. With SafeCare AI software suite, hospitals can admit patients, identify in real-time patients at risk, and initiate treatment interventions with proactive real-time decision support throughout the stay. SafeCare AI Suite allows hospitals to focus on outcomes, not administrative duties, while reducing cost."

Leveraging machine learning and deep-learning capabilities, SafeCare AI Suite fosters a new generation of AI applications, which are able to sense, reason, act and adapt, to address a range of healthcare challenges in areas such readmissions, medical errors, infections, cost, and outpatient utilization.

There are SafeCare AI applications to:
• Reduce Redundant Care
• Cut Avoidable Readmissions
• Lower Hospital Charges
• Reduce Inpatient Mortality
• Prevent Hospital Infections
• Predict Sepsis Progression
•Improve Medication Safety

SafeCare AI Suite can be purchased as a standalone software platform or together with other software applications that can help hospital rankings.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.